Anionic pulmonary surfactant lipid regulation of innate immunity.
Mari
M
Numata
Pitchaimani
P
Kandasamy
Dennis R
DR
Voelker
D000818:Animals; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D018836:Inflammation Mediators / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000276:immunology / Q000378:metabolism* / Q000382:microbiology / Q000821:virology; D010715:Phosphatidylglycerols / Q000378:metabolism* / Q000627:therapeutic use; D037661:Pulmonary Surfactant-Associated Proteins / Q000378:metabolism*; D012141:Respiratory Tract Infections / Q000276:immunology / Q000378:metabolism / Q000382:microbiology / Q000517:prevention & control* / Q000821:virology; D015398:Signal Transduction / Q000187:drug effects; D051195:Toll-Like Receptor 2 / Q000378:metabolism; D051197:Toll-Like Receptor 4 / Q000378:metabolism
D018836:Inflammation Mediators; D010715:Phosphatidylglycerols; D037661:Pulmonary Surfactant-Associated Proteins; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4; C060037:1-palmitoyl-2-oleoylglycero-3-phosphoglycerol